AI Survival Model Predicts Lung Cancer Drug Resistance
Researchers have developed a sophisticated AI model that can predict which lung cancer patients will develop resistance to aumolertinib. The system analyzed five major cancer datasets to identify high-risk patients who might benefit from alternative treatments.